United States

OxyContin maker now in the opioid addiction treatment business

Rhodes Technologies Inc. has been granted a patent for a new drug that could help treat opioid addiction. This sounds like good news at first — like someone’s actually doing something to fight the epidemic that’s destroying lives across the country at an alarming rate. It sounds like good news, until you realize that Rhodes Technologies Inc. is a subsidiary of Purdue Pharma, the same company that many hold responsible for starting the opioid epidemic in the first place because they flooded the market with OxyContin and allegedly suppressed reports of the drug’s addictive properties for years. Purdue Pharma is currently in the midst of several lawsuits accusing them of deceptively marketing OxyContin as non-addictive, and igno ...